Filippo Pietrantonio
Agency for Science, Technology and Research(SG)SingHealth(SG)National University of Singapore(SG)European Neuroendocrine Tumor Society(DE)SingHealth Duke-NUS Academic Medical Centre(SG)Duke-NUS Medical School(SG)Istituti di Ricovero e Cura a Carattere Scientifico(IT)Fondazione IRCCS Istituto Nazionale dei Tumori(IT)Genome Institute of Singapore(SG)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Gastric Cancer Management and Outcomes, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth(2017)617 cited
- → Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis(2015)492 cited
- → Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer(2019)463 cited
- → Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan(2018)399 cited
- → Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients(2020)355 cited
- → The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials